CHMP2B and amyotrophic lateral sclerosis: Although many behavioral studies focus predominantly in motor dysfunction, other animal models have shown cognitive and social deficits consistent mostly with the FTD end of the FTD/ALS disease spectrum, i.e., those based in FTD-associated genes including tau, PRGN, CHMP2B and others.